HomeCompareCSAMF vs CHD

CSAMF vs CHD: Dividend Comparison 2026

CSAMF yields 9.90% · CHD yields 1.28%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CSAMF wins by $407896.09M in total portfolio value
10 years
CSAMF
CSAMF
● Live price
9.90%
Share price
$4.82
Annual div
$0.48
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$407896.11M
Annual income
$400,131,239,290.63
Full CSAMF calculator →
CHD
CHD
● Live price
1.28%
Share price
$93.32
Annual div
$1.19
5Y div CAGR
23.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$26.4K
Annual income
$1,302.64
Full CHD calculator →

Portfolio growth — CSAMF vs CHD

📍 CSAMF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCSAMFCHD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CSAMF + CHD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CSAMF pays
CHD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CSAMF
Annual income on $10K today (after 15% tax)
$841.44/yr
After 10yr DRIP, annual income (after tax)
$340,111,553,397.04/yr
CHD
Annual income on $10K today (after 15% tax)
$108.62/yr
After 10yr DRIP, annual income (after tax)
$1,107.24/yr
At 15% tax rate, CSAMF beats the other by $340,111,552,289.79/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CSAMF + CHD for your $10,000?

CSAMF: 50%CHD: 50%
100% CHD50/50100% CSAMF
Portfolio after 10yr
$203948.07M
Annual income
$200,065,620,296.64/yr
Blended yield
98.10%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on CHD right now

CSAMF
No analyst data
Altman Z
1.1
Piotroski
4/9
CHD
Analyst Ratings
18
Buy
15
Hold
1
Sell
Consensus: Buy
Price Target
$98.40
+5.4% upside vs current
Range: $82.00 — $110.00
Altman Z
4.9
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CSAMF buys
0
CHD buys
0
No recent congressional trades found for CSAMF or CHD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCSAMFCHD
Forward yield9.90%1.28%
Annual dividend / share$0.48$1.19
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%23.1%
Portfolio after 10y$407896.11M$26.4K
Annual income after 10y$400,131,239,290.63$1,302.64
Total dividends collected$407370.38M$5.5K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: CSAMF vs CHD ($10,000, DRIP)

YearCSAMF PortfolioCSAMF Income/yrCHD PortfolioCHD Income/yrGap
1← crossover$12,680$1,979.87$10,857$157.30+$1.8KCSAMF
2$18,260$4,692.42$11,814$196.49+$6.4KCSAMF
3$32,169$12,630.66$12,887$245.97+$19.3KCSAMF
4$76,012$41,591.87$14,097$308.68+$61.9KCSAMF
5$265,032$183,698.34$15,473$388.49+$249.6KCSAMF
6$1,480,778$1,197,194.33$17,046$490.55+$1.46MCSAMF
7$14,087,114$12,502,681.79$18,861$621.76+$14.07MCSAMF
8$237,394,699$222,321,486.64$20,973$791.47+$237.37MCSAMF
9$7,256,891,462$7,002,879,134.27$23,454$1,012.51+$7256.87MCSAMF
10$407,896,113,155$400,131,239,290.63$26,398$1,302.64+$407896.09MCSAMF

CSAMF vs CHD: Complete Analysis 2026

CSAMFStock

CSAM Health Group AS provides various ehealth solutions in Norway and internationally. The company offers CSAM Arcidis, an integrated system for teleradiology; CSAM DICOM Server for handling radiology data; CSAM HelseMail for transfer of confidential patient data between healthcare organizations; CSAM Infobroker, a vendor-neutral telemedicine system for radiology that enables multiple clinicians to share resources and knowledge; CSAM S7, a platform for self-care and health counselling; CSAM Web Client, a web-based user interface and connectivity solution that allows users to access multiple CSAM applications and functions; and CSAM XDS, a central archive for storing and managing various types of clinical patient data. It also provides CSAM Cardio, an ECG and diagnostic storage tool; CSAM CIMA, a mobile application for capturing, using, and sending medical media; CSAM Media, a web-based medical imaging solution; CSAM Medimaker for image management and workflow solution; CSAM Picsara, an image management solution; and CSAM TRIS, a radiology information system. In addition, the company offers CSAM Partus, a maternity information system; CSAM Natus, a maternity care system; CSAM iPana Labor Information System, a web-based labour information system; CSAM iPana Maternity, a cloud-based service platform that enables expectant mothers, hospitals, and maternity clinics to electronically collect, store, and share medical information; and CSAM Fertsoft, a care and practice management software. Further, it provides CSAM Optima Predict solution for operational planning; CSAM Optima Live; CSAM AMIS, an emergency medical information system; CSAM IMTS, a tool for assessing and prioritizing patients; CSAM Paratus, an emergency response system; CSAM CoordCom; CSAM ResQMobile; CSAM Cytodose, an oncology management solution; and CSAM ProSang, an advanced laboratory information management system. The company was founded in 1999 and is headquartered in Oslo, Norway.

Full CSAMF Calculator →

CHDConsumer Staples

Church & Dwight Co., Inc. develops, manufactures, and markets household, personal care, and specialty products. It operates through three segments: Consumer Domestic, Consumer International, and Specialty Products Division. The company offers cat litters, carpet deodorizers, laundry detergents, and baking soda, as well as other baking soda based products under the ARM & HAMMER brand; condoms, lubricants, and vibrators under the TROJAN brand; stain removers, cleaning solutions, laundry detergents, and bleach alternatives under the OXICLEAN brand; battery-operated and manual toothbrushes under the SPINBRUSH brand; home pregnancy and ovulation test kits under the FIRST RESPONSE brand; depilatories under the NAIR brand; oral analgesics under the ORAJEL brand; laundry detergents under the XTRA brand; gummy dietary supplements under the L'IL CRITTERS and VITAFUSION brands; dry shampoos under the BATISTE brand; water flossers and replacement showerheads under the WATERPIK brand; FLAWLESS products; cold shortening and relief products under the ZICAM brand; and oral care products under the THERABREATH brand. Its specialty products include animal productivity products, such as MEGALAC rumen bypass fat, a supplement that enables cows to maintain energy levels during the period of high milk production; BIO-CHLOR and FERMENTEN, which are used to reduce health issues associated with calving, as well as provides needed protein; and CELMANAX refined functional carbohydrate, a yeast-based prebiotic. The company offers sodium bicarbonate; and cleaning and deodorizing products. It sells its consumer products through supermarkets, mass merchandisers, wholesale clubs, drugstores, convenience stores, home stores, dollar and other discount stores, pet and other specialty stores, and websites and other e-commerce channels; and specialty products to industrial customers and livestock producers through distributors. The company was founded in 1846 and is headquartered in Ewing, New Jersey.

Full CHD Calculator →
📬

Get this CSAMF vs CHD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CSAMF vs SCHDCSAMF vs JEPICSAMF vs OCSAMF vs KOCSAMF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.